Association between adherens junctions and tight junctions via rap1 promotes barrier protective effects of oxidized phospholipids
- 6 December 2010
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 226 (8), 2052-2062
- https://doi.org/10.1002/jcp.22543
Abstract
Previous studies showed that cyclopenthenone‐containing products resulting from oxidation of a natural phospholipid, 1‐palmitoyl‐2‐arachidonoyl‐sn‐glycero‐3‐phosphorylcholine (OxPAPC) exhibit potent barrier‐protective effects in the in vitro and in vivo models of lung endothelial cell (EC) barrier dysfunction, and these effects are associated with enhancement of peripheral actin cytoskeleton, cell–cell and cell–substrate contacts driven by activation of Rac and Cdc42 GTPases. Rap1 GTPase is another member of small GTPase family involved in control of cell–cell interactions; however, its involvement in EC barrier‐protective effects by OxPAPC remains unknown. This study examined a role of Rap1 in regulation of OxPAPC‐induced interactions in adherens junctions (AJ) and tight junctions (TJ) as a novel mechanism of EC barrier preservation in vitro and in vivo. Immunofluorescence analysis, subcellular fractionation, and co‐immunoprecipitation assays indicate that OxPAPC promoted accumulation of AJ proteins: VE‐cadherin, p120‐catenin, and β‐catenin; and TJ proteins: ZO‐1, occludin, and JAM‐A in the cell membrane, and induced novel cross‐interactions between AJ and TJ protein complexes, that were dependent on OxPAPC‐induced Rap1 activation. Inhibition of Rap1 function suppressed OxPAPC‐mediated pulmonary EC barrier enhancement and AJ and TJ interactions in vitro, as well as inhibited protective effects of OxPAPC against ventilator‐induced lung injury in vivo. These results show for the first time a role of Rap1‐mediated association between adherens junctions and tight junction complexes in the OxPAPC‐induced pulmonary vascular EC barrier protection. J. Cell. Physiol. 226: 2052–2062, 2011.Keywords
This publication has 66 references indexed in Scilit:
- Rac GTPase is a hub for protein kinase A and Epac signaling in endothelial barrier protection by cAMPMicrovascular Research, 2009
- Rap1 mediates protective effects of iloprost against ventilator-induced lung injuryJournal of Applied Physiology, 2009
- Oxidized phospholipids in control of inflammation and endothelial barrierTranslational Research, 2009
- Akt-Mediated Transactivation of the S1P 1 Receptor in Caveolin-Enriched Microdomains Regulates Endothelial Barrier Enhancement by Oxidized PhospholipidsCirculation Research, 2009
- Cross talk between paxillin and Rac is critical for mediation of barrier-protective effects by oxidized phospholipidsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- E‐cadherin dis‐engagement activates the Rap1 GTPaseJournal of Cellular Biochemistry, 2008
- Epac/Rap and PKA are novel mechanisms of ANP‐induced Rac‐mediated pulmonary endothelial barrier protectionJournal of Cellular Physiology, 2007
- Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protectionMicrovascular Research, 2007
- Prostaglandins PGE2 and PGI2 promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activationExperimental Cell Research, 2007
- Rap1 signalling: adhering to new modelsNature Reviews Molecular Cell Biology, 2001